Intrauterine Devices, Copper
Intrauterine Device Migration
Uterine Perforation
Contraceptive Agents, Female
Levonorgestrel
Contraception
Pelvic Inflammatory Disease
Contraceptive Devices
Family Planning Services
Contraception, Postcoital
Foreign-Body Migration
Pyometra
Pregnancy, Unplanned
Gynecology
Urinary Bladder Calculi
Uterine Hemorrhage
Contraceptives, Oral
Sterilization, Tubal
Metrorrhagia
Pregnancy, Ectopic
Contraceptives, Oral, Hormonal
Pregnancy
Sterilization, Reproductive
Desogestrel
Menstruation
Cervix Mucus
Abortion, Induced
Progestins
Medroxyprogesterone
Device Approval
Medroxyprogesterone Acetate
Drug Implants
Pelvis
Uterus
Parity
Contraceptive needs of women attending a genitourinary medicine clinic for the first time. (1/352)
OBJECTIVE: To assess the need for, and potential uptake of, a contraceptive service within a genitourinary medicine (GUM) clinic. METHODS: 544 women, median age 17 years (range 13-54) including 142 teenagers, attending the Fife GUM clinics serving a semirural population of 350,000 for the first time in the 12 month period from 1 September 1995 to 31 August 1996 were interviewed. RESULTS: Contraception was required by 353, of whom only 5% (29) were at risk of unplanned pregnancy, although half (15) of these were teenagers. 23 of 29 (79%) stated that they would access contraception at a GUM clinic if it were available. Of women using contraception, 67% (217/324) were taking the oral contraceptive pill (OCP), of whom 177 obtained supplies from their general practitioners and were happy with this. However, 92/177 (52%) stated that they would access the OCP at GUM clinics if it were available. Overall, of the 243 women who stated that they would access contraception at the GUM clinic, 23 of whom were currently at risk of an unplanned pregnancy, the demand was principally for condoms and the OCP. CONCLUSION: The majority of women attending GUM clinics for the first time are using contraception, or have deliberately chosen not to do so. Only 5% were at risk of unplanned pregnancy. In general, the women using contraception were happy with their current source of contraception, but about two thirds would use a contraceptive service at GUM clinics if it were available at the time they were attending the clinic. It was found that teenagers accounted for half of those women at risk of unwanted pregnancy. However, the majority of teenagers requiring contraception would consider obtaining it from GUM clinics. (+info)Preventing repeat adolescent pregnancies with early adoption of the contraceptive implant. (2/352)
CONTEXT: Even in intensive, adolescent-oriented programs, in which access to highly effective contraceptives is guaranteed, repeat adolescent pregnancies commonly occur. METHODS: To assess whether adoption of the contraceptive implant would lower the rate of repeat pregnancy, contraceptive use and pregnancy outcomes were tracked among 309 adolescent mothers--171 "early" implant users who began use within six months of delivery and 138 who either adopted another method or had used no method. Participants were interviewed at delivery and at six-month intervals through the second year postpartum. Multivariate logistic regression analyses were conducted to ascertain the likelihood of a repeat pregnancy within the first and second year postpartum. RESULTS: During the first year postpartum, although 7% of the early implant users had their implants removed, pregnancy rates were significantly (p < .0001) lower among early implant users (less than 1%) than among the other adolescent mothers in the sample (20%). By the end of the second year postpartum, 37% of early implant users had discontinued use. Nevertheless, their two-year pregnancy rate (12%) remained significantly lower (p < .0001) than that of the other adolescent mothers (46%). The multivariate analysis showed that early implant use was the only independent predictor of a repeat pregnancy within the first year postpartum, while early use, parity and number of risk factors for repeat pregnancy were independently associated with the likelihood of another pregnancy in the second year postpartum. CONCLUSIONS: Although early implant insertion significantly decreased the rate of rapid, repeat adolescent pregnancies, the rates of removal and of pregnancy by the end of the second year postpartum were high. Thus, health care providers need to address the motivational components of adolescent pregnancy even among those who accept ostensibly long-term methods. (+info)Reproductive factors of ovarian and endometrial cancer risk in a high fertility population in Mexico. (3/352)
A case-control study was carried out in Mexico City during 1995-1997 among women with epithelial ovarian cancer (84 cases) and endometrial cancer (85 cases). The control group consisted of 668 healthy women, matched according to age categories. In a multivariate analysis, the reproductive risk factors for ovarian and endometrial cancer are similar. The risk of ovarian cancer was inversely related to the number of full-term pregnancies; the odds ratio (OR) was 0.17 and the 95% confidence interval (CI) was 0.05-0.54 when comparing nulliparous women versus those with more than seven pregnancies. For endometrial cancer, a similar association was observed (OR, 0.11; 95% CI, 0.04-0.34). The use of oral contraceptive hormones was inversely associated with both ovarian (OR, 0.36; 95% CI, 0.15-0.83) and endometrial cancer risk (OR, 0.36; 95% CI, 0.14-0.90). In women with a history of more than 8.7 years without ovulation, the risk of ovarian cancer decreased four times (OR, 0.23; 95% CI, 0.10-0.50), and that of endometrial cancer decreased more than five times (OR, 0.17; 95% CI, 0.08-0.35). These two neoplasms are clearly typified as hormone dependent, and it is possible to establish that "ovulation" and "exfoliative" mechanisms jointly determine the level of risk for both ovarian and endometrial cancer. (+info)Safety and efficacy of fertility-regulating methods: a decade of research. (4/352)
An international venture was launched in 1985 to fill a recognized gap in post-marketing surveillance of fertility-regulating methods. For this purpose a new task force was set up by the Special Programme of Research, Development, and Research Training in Human Reproduction, which is cosponsored by the United Nations Development Programme, the United Nations Population Fund, the World Bank, and WHO. Research priorities were chosen and epidemiological studies inaugurated, involving a total of 47 countries--mostly from the developing world. Important progress has been made, especially in helping to define the beneficial and possible adverse effects of oral contraceptives on the risk of neoplasia; in showing that the injectable contraceptive depot-medroxyprogesterone acetate protects against endometrial cancer and does not increase the overall risk of breast cancer, in clarifying which groups of women are susceptible to the rare cardiovascular complications of oral contraceptives (myocardial infarction, stroke, and venous thromboembolism); and in establishing the long-term effectiveness and safety of intrauterine devices. The research has already made a significant impact on family planning policies and practice. Critical appraisal of this venture, which has been modestly funded, confirms the value of mission-oriented research. It also illustrates the potential of collaboration that bridges the global divide between developing and developed countries. (+info)Bone mineral density during long-term use of the progestagen contraceptive implant Implanon compared to a non-hormonal method of contraception. (5/352)
An open, prospective, comparative study was done in healthy women, aged between 18 and 40 years, to study the effects of long-term etonogestrel treatment on bone mineral density (BMD). The control group used a non-hormone-medicated intrauterine device (IUD). The BMD was measured using a dual energy X-ray absorptiometry instrument. Measurements included the lumbar spine (L(2)-L(4)), the proximal femur (femoral neck, Ward's triangle, trochanter) and distal radius. The period of treatment was 2 years and 44 women in the Implanon group and 29 in the IUD group provided data. Groups were comparable at baseline with respect to age, weight, body mass index, BMD and 17beta-oestradiol status. Changes from baseline in BMD in the Implanon group were not essentially different from those in the IUD group. There was no relationship between 17beta-oestradiol concentrations and changes in BMD in this study population. The results of the present study indicate that Implanon((R)) can safely be used in young women who have not yet achieved their peak bone mass. (+info)Endometrial lysosomal enzyme activity in ovulatory dysfunctional uterine bleeding, IUCD users and post-partum women. (6/352)
The aim of this study was to evaluate the role of lysosomal enzymes in excessively heavy menstruation by comparing women with menorrhagia due to dysfunctional bleeding or intrauterine contraceptive device (IUCD) use with those with normal menstrual periods or with amenorrhoea associated with breastfeeding. This was a prospective cohort investigation of the activity of four endometrial lysosomal enzymes in three contrasting groups: (i) women with ovulatory dysfunctional uterine bleeding and users of intrauterine contraceptive devices; (ii) breastfeeding post-partum women in whom there are long periods of amenorrhoea, particularly in the early months post-partum; and (iii) normal cycling women. It was found that the total activity of lysosomal enzymes, particularly acid phosphatase and N-acetyl-beta-D-glucosaminidase, was markedly elevated (P < 0.001) in IUCD-exposed endometrium, and endometrium from women with dysfunctional uterine bleeding when compared with endometrium from women with a history of entirely normal menstrual periods or that in post-partum breastfeeding women. The activity of alpha-L-fucosidase was moderately elevated in IUCD users (P < 0.05) and ovulatory dysfunctional uterine bleeding (P < 0.05), whereas alphaD-mannosidase activity was elevated in ovulatory dysfunctional uterine bleeding (P < 0.05), but decreased in IUCD users (P < 0.01). No significant differences were observed in the lysosomal enzyme activities of breastfeeding post-partum women and normal cycling women. These results show that total endometrial tissue activity of four lysosomal enzymes was substantially increased throughout the cycle in most circumstances in women with two different causes for increased menstrual bleeding. This suggests a contributory role to the increased bleeding. (+info)The influence of husbands on contraceptive use by Bangladeshi women. (7/352)
This study uses the 1993-94 Bangladesh DHS to evaluate the effect of the woman's perception of her husband's approval of family planning on her current and future use of modern contraception, after controlling for selected socioeconomic and demographic factors. While most husbands support family planning, contraceptive use among those whose husbands do not approve of family planning is much lower. In some areas of Bangladesh, however, husband's disapproval of family planning is still a major deterrent factor for woman's fertility control. As husband's approval does appear to be a major determinant of contraceptive uptake in similar developing countries in the region, more effective male targeting may be necessary for maintaining the success of the family planning programme in future. (+info)Fertility outcome after ectopic pregnancy and use of an intrauterine device at the time of the index ectopic pregnancy. (8/352)
Fertility after ectopic pregnancy (EP) was investigated in a non-selected population taking into account intrauterine device (IUD) use at the time of the EP. Between January 1992 and June 1996, 647 women listed in the EP register of Auvergne (France) were followed up. The analysis included only the 328 women who were seeking to become pregnant: 23 women using IUD at the time of the index EP (IUD users) and 305 IUD non-users. Among IUD users, there was no recurrence of EP, and the 1 year cumulative rate was 87% [95% confidence interval (CI): 73-100%] for intrauterine pregnancies and 86% (95% CI: 72-100%) for deliveries. Among IUD non-users, the 2 year cumulative rate for recurrence of EP was 28% (95% CI: 17-39%), and the 1 year cumulative rates were 60% (95% CI: 53-66%) for intrauterine pregnancies and 44% (95% CI: 38-56%) for deliveries. The adjusted intrauterine pregnancy rate of IUD users was not significantly different from that of IUD non-users. However, IUD non-users had more miscarriages, so their delivery rate was lower. (+info)An Intrauterine Device (IUD) is a long-acting, reversible contraceptive device that is inserted into the uterus to prevent pregnancy. It is a small T-shaped piece of flexible plastic with strings attached to it for removal. There are two types of IUDs available: hormonal and copper. Hormonal IUDs release progestin, which thickens cervical mucus and thins the lining of the uterus, preventing sperm from reaching and fertilizing an egg. Copper IUDs, on the other hand, produce an inflammatory reaction in the uterus that is toxic to sperm and eggs, preventing fertilization.
IUDs are more than 99% effective at preventing pregnancy and can remain in place for several years, depending on the type. They are easily removable by a healthcare provider if a woman wants to become pregnant or choose another form of contraception. IUDs do not protect against sexually transmitted infections (STIs), so it is important to use condoms in addition to an IUD for protection against STIs.
In summary, Intrauterine Devices are small, T-shaped plastic devices that are inserted into the uterus to prevent pregnancy. They come in two types: hormonal and copper, both of which work by preventing fertilization. IUDs are highly effective, long-acting, and reversible forms of contraception.
An Intrauterine Device (IUD) is a small, T-shaped device that is inserted into the uterus to prevent pregnancy. The copper IUD is a type of long-acting reversible contraception (LARC) that releases copper ions, which are toxic to sperm and egg, preventing fertilization. It is one of the most effective forms of birth control available, with a failure rate of less than 1%.
The copper IUD can be used by women who have previously given birth as well as those who have not. It can be inserted up to five days after unprotected intercourse as emergency contraception to prevent pregnancy. Once inserted, the copper IUD can remain in place for up to ten years, although it can be removed at any time if a woman wants to become pregnant or for other reasons.
Copper IUDs are also used as an effective treatment for heavy menstrual bleeding and can be used to manage endometriosis-associated pain. Common side effects of copper IUDs include heavier and longer menstrual periods, cramping during insertion, and irregular periods during the first few months after insertion. However, these side effects usually subside over time.
It is important to note that while copper IUDs are highly effective at preventing pregnancy, they do not protect against sexually transmitted infections (STIs). Therefore, it is still recommended to use condoms or other barrier methods of protection during sexual activity to reduce the risk of STIs.
An intrauterine device (IUD) is a small, T-shaped birth control device that is inserted into the uterus to prevent pregnancy. A medicated IUD is a type of IUD that contains hormones, which are released slowly over time to provide additional benefits beyond just contraception.
There are two types of medicated IUDs available in the US market: levonorgestrel-releasing intrauterine system (LNG-IUS) and the copper intrauterine device (Cu-IUD). The LNG-IUS releases a progestin hormone called levonorgestrel, which thickens cervical mucus to prevent sperm from reaching the egg, thins the lining of the uterus to make it less likely for a fertilized egg to implant, and can also inhibit ovulation in some women. The Cu-IUD is non-hormonal and works by releasing copper ions that create a toxic environment for sperm, preventing them from reaching the egg.
Medicated IUDs are highly effective at preventing pregnancy, with typical use failure rates of less than 1% per year. They can remain in place for several years, depending on the brand, and can be removed at any time by a healthcare provider if a woman wants to become pregnant or experience side effects. Common side effects of medicated IUDs may include irregular menstrual bleeding, cramping, and spotting between periods, although these tend to improve over time.
Intrauterine Device (IUD) expulsion is a medical condition that refers to the unintentional and partial or complete removal of an IUD from the uterus after its initial insertion. This can occur spontaneously or as a result of manipulation, and it may happen soon after insertion or even several months or years later.
IUD expulsion is more common in women who have not previously given birth, and it can increase the risk of unintended pregnancy and other complications. Symptoms of IUD expulsion may include irregular menstrual bleeding, pelvic pain, or the absence of the IUD strings in the vagina. If a woman suspects that her IUD has been expelled, she should contact her healthcare provider for further evaluation and management.
Intrauterine Device (IUD) migration is a medical condition where the IUD, a long-acting reversible contraceptive device placed inside the uterus, moves from its original position. Normally, an IUD is designed to remain in the uterus, with the vertical strings attached to it trailing down through the cervix into the vagina, allowing for easy removal or checking of its position.
IUD migration refers to the unintended movement of the device, either partially or completely, outside the uterine cavity. This may occur due to various reasons such as a weakened uterus, infection, or anatomical abnormalities. The migration can lead to complications like perforation of the uterus, damage to nearby organs, and difficulty in removing or locating the IUD. Regular check-ups with healthcare providers are essential to ensure that the IUD remains in its proper place and to address any potential issues early on.
Uterine perforation is a medical condition that refers to the piercing or puncturing of the uterine wall. This can occur during various medical procedures such as dilatation and curettage (D&C), insertion of an intrauterine device (IUD), or during childbirth. It can also be caused by trauma or infection. Uterine perforation can lead to serious complications, such as bleeding, infection, and damage to surrounding organs. If left untreated, it can be life-threatening. Symptoms of uterine perforation may include severe abdominal pain, heavy vaginal bleeding, fever, and signs of shock. Immediate medical attention is required for proper diagnosis and treatment.
Contraceptive agents, female, are medications or devices specifically designed to prevent pregnancy in women. They work by interfering with the normal process of ovulation, fertilization, or implantation of a fertilized egg in the uterus. Some common examples of female contraceptive agents include:
1. Hormonal methods: These include combined oral contraceptives (COCs), progestin-only pills, patches, vaginal rings, and hormonal implants. They contain synthetic forms of the female hormones estrogen and/or progesterone, which work by preventing ovulation, thickening cervical mucus to make it harder for sperm to reach the egg, or thinning the lining of the uterus to prevent implantation of a fertilized egg.
2. Intrauterine devices (IUDs): These are small, T-shaped devices made of plastic or copper that are inserted into the uterus by a healthcare provider. They release hormones or copper ions that interfere with sperm movement and prevent fertilization or implantation.
3. Barrier methods: These include condoms, diaphragms, cervical caps, and sponges. They work by physically preventing sperm from reaching the egg.
4. Emergency contraception: This includes medications such as Plan B or Ella, which can be taken up to 5 days after unprotected sex to prevent pregnancy. They work by delaying ovulation or preventing fertilization of the egg.
5. Fertility awareness-based methods (FABMs): These involve tracking a woman's menstrual cycle and avoiding sexual intercourse during her fertile window. Some FABMs also involve using barrier methods during this time.
It is important to note that different contraceptive agents have varying levels of effectiveness, side effects, and risks. Women should consult with their healthcare provider to determine the best method for their individual needs and circumstances.
Levonorgestrel is a synthetic form of the natural hormone progesterone, which is used in various forms of birth control and emergency contraceptives. It works by preventing ovulation (the release of an egg from the ovaries), thickening cervical mucus to make it harder for sperm to reach the egg, and thinning the lining of the uterus to make it less likely for a fertilized egg to implant.
Medically, Levonorgestrel is classified as a progestin and is available in various forms, including oral tablets, intrauterine devices (IUDs), and emergency contraceptive pills. It may also be used to treat endometriosis, irregular menstrual cycles, and heavy menstrual bleeding.
It's important to note that while Levonorgestrel is a highly effective form of birth control when used correctly, it does not protect against sexually transmitted infections (STIs). Therefore, condoms should still be used during sexual activity if there is any risk of STI transmission.
Contraception is the use of various devices, methods, or medications to prevent pregnancy. The term is derived from the Latin words "contra" meaning "against" and "conceptio" meaning "conception." Contraceptive methods can be broadly categorized into temporary and permanent methods. Temporary methods include barriers such as condoms, diaphragms, cervical caps, and sponges; hormonal methods like the pill, patch, ring, injection, and emergency contraception; and fertility awareness-based methods that involve tracking ovulation and avoiding intercourse during fertile periods. Permanent methods include surgical procedures such as tubal ligation for women and vasectomy for men.
The primary goal of contraception is to prevent the sperm from reaching and fertilizing the egg, thereby preventing pregnancy. However, some contraceptive methods also offer additional benefits such as reducing the risk of sexually transmitted infections (STIs) and regulating menstrual cycles. It's important to note that while contraception can prevent pregnancy, it does not protect against STIs, so using condoms is still recommended for individuals who are at risk of contracting STIs.
When choosing a contraceptive method, it's essential to consider factors such as effectiveness, safety, ease of use, cost, and personal preferences. It's also important to consult with a healthcare provider to determine the most appropriate method based on individual health history and needs.
Actinomycosis is a type of infection caused by bacteria that are normally found in the mouth, intestines, and female genital tract. These bacteria can cause abscesses or chronic inflammation if they infect body tissues, often after trauma or surgery. The infection typically affects the face, neck, or chest, and can spread to other parts of the body over time. Symptoms may include swelling, redness, pain, and the formation of pus-filled abscesses that may discharge a characteristic yellowish granular material called "sulfur granules." Treatment typically involves long-term antibiotic therapy, often requiring high doses and intravenous administration. Surgical drainage or removal of infected tissue may also be necessary in some cases.
Contraceptive devices for females refer to medical products designed to prevent pregnancy by blocking or interfering with the sperm's ability to reach and fertilize an egg. Some common examples of female contraceptive devices include:
1. Diaphragm: A shallow, flexible dome made of silicone that is inserted into the vagina before sexual intercourse to cover the cervix and prevent sperm from entering the uterus.
2. Cervical Cap: Similar to a diaphragm but smaller in size, the cervical cap fits over the cervix and creates a barrier to sperm entry.
3. Intrauterine Device (IUD): A small, T-shaped device made of plastic or copper that is inserted into the uterus by a healthcare professional. IUDs can prevent pregnancy for several years and work by changing the chemistry of the cervical mucus and uterine lining to inhibit sperm movement and implantation of a fertilized egg.
4. Contraceptive Sponge: A soft, round sponge made of polyurethane foam that contains spermicide. The sponge is inserted into the vagina before sexual intercourse and covers the cervix to prevent sperm from entering the uterus.
5. Female Condom: A thin, flexible pouch made of polyurethane or nitrile that is inserted into the vagina before sexual intercourse. The female condom creates a barrier between the sperm and the cervix, preventing pregnancy and reducing the risk of sexually transmitted infections (STIs).
6. Vaginal Ring: A flexible ring made of plastic that is inserted into the vagina for three weeks at a time to release hormones that prevent ovulation, thicken cervical mucus, and thin the lining of the uterus.
7. Contraceptive Implant: A small, flexible rod made of plastic that is implanted under the skin of the upper arm by a healthcare professional. The implant releases hormones that prevent ovulation and thicken cervical mucus to prevent pregnancy for up to three years.
It's important to note that while these contraceptive devices can be highly effective at preventing pregnancy, they do not protect against STIs. Using condoms in addition to other forms of contraception is recommended to reduce the risk of both pregnancy and STIs.
Pelvic Inflammatory Disease (PID) is a medical condition characterized by inflammation of the reproductive organs in women, specifically the uterus, fallopian tubes, and/or ovaries. It is often caused by an infection that ascends from the cervix or vagina into the upper genital tract. The infectious agents are usually sexually transmitted bacteria such as Neisseria gonorrhoeae and Chlamydia trachomatis, but other organisms can also be responsible.
Symptoms of PID may include lower abdominal pain, irregular menstrual bleeding, vaginal discharge with an unpleasant odor, fever, painful sexual intercourse, or pain in the lower back. However, some women with PID may not experience any symptoms at all. If left untreated, PID can lead to serious complications such as infertility, ectopic pregnancy, and chronic pelvic pain.
Diagnosis of PID is typically based on a combination of clinical findings, physical examination, and laboratory tests. Treatment usually involves antibiotics to eradicate the infection and may also include pain management and other supportive measures. In some cases, hospitalization may be necessary for more intensive treatment or if complications arise.
"Device Removal" in a medical context generally refers to the surgical or nonsurgical removal of a medical device that has been previously implanted in a patient's body. The purpose of removing the device may vary, depending on the individual case. Some common reasons for device removal include infection, malfunction, rejection, or when the device is no longer needed.
Examples of medical devices that may require removal include pacemakers, implantable cardioverter-defibrillators (ICDs), artificial joints, orthopedic hardware, breast implants, cochlear implants, and intrauterine devices (IUDs). The procedure for device removal will depend on the type of device, its location in the body, and the reason for its removal.
It is important to note that device removal carries certain risks, such as bleeding, infection, damage to surrounding tissues, or complications related to anesthesia. Therefore, the decision to remove a medical device should be made carefully, considering both the potential benefits and risks of the procedure.
Contraceptive devices are medical products or tools specifically designed to prevent pregnancy by blocking or interfering with the fertilization of an egg by sperm, or the implantation of a fertilized egg in the uterus. There are various types of contraceptive devices available, each with its own mechanism of action and efficacy rate. Here are some common examples:
1. Intrauterine Devices (IUDs): These are small, T-shaped devices made of plastic or copper that are inserted into the uterus by a healthcare professional. IUDs can prevent pregnancy for several years and work by affecting the movement of sperm and changing the lining of the uterus to make it less receptive to implantation.
2. Contraceptive Implants: These are small, flexible rods that are inserted under the skin of the upper arm by a healthcare professional. The implant releases hormones that prevent ovulation and thicken cervical mucus to block sperm from reaching the egg.
3. Diaphragms and Cervical Caps: These are flexible, dome-shaped devices made of silicone or rubber that are inserted into the vagina before sex. They cover the cervix and prevent sperm from entering the uterus.
4. Male and Female Condoms: These are thin sheaths made of latex, polyurethane, or other materials that are placed over the penis (male condom) or inside the vagina (female condom) during sex to prevent sperm from entering the body.
5. Spermicides: These are chemicals that kill or disable sperm and can be used alone or in combination with other contraceptive methods such as condoms, diaphragms, or cervical caps. They come in various forms, including foams, creams, gels, films, and suppositories.
It's important to note that while contraceptive devices are effective at preventing pregnancy, they do not protect against sexually transmitted infections (STIs). Using condoms is the best way to reduce the risk of STIs during sexual activity.
Family planning services refer to comprehensive healthcare programs and interventions that aim to help individuals and couples prevent or achieve pregnancies, according to their desired number and spacing of children. These services typically include:
1. Counseling and education: Providing information about various contraceptive methods, their effectiveness, side effects, and appropriate use. This may also include counseling on reproductive health, sexually transmitted infections (STIs), and preconception care.
2. Contraceptive services: Making a wide range of contraceptive options available to clients, including barrier methods (condoms, diaphragms), hormonal methods (pills, patches, injectables, implants), intrauterine devices (IUDs), and permanent methods (tubal ligation, vasectomy).
3. Screening and testing: Offering STI screening and testing, as well as cervical cancer screening for eligible clients.
4. Preconception care: Providing counseling and interventions to help women achieve optimal health before becoming pregnant, including folic acid supplementation, management of chronic conditions, and avoidance of harmful substances (tobacco, alcohol, drugs).
5. Fertility services: Addressing infertility issues through diagnostic testing, counseling, and medical or surgical treatments when appropriate.
6. Menstrual regulation: Providing manual vacuum aspiration or medication to safely and effectively manage incomplete miscarriages or unwanted pregnancies within the first trimester.
7. Pregnancy options counseling: Offering unbiased information and support to help individuals make informed decisions about their pregnancy, including parenting, adoption, or abortion.
8. Community outreach and education: Engaging in community-based initiatives to increase awareness of family planning services and promote reproductive health.
9. Advocacy: Working to remove barriers to accessing family planning services, such as policy changes, reducing stigma, and increasing funding for programs.
Family planning services are an essential component of sexual and reproductive healthcare and contribute significantly to improving maternal and child health outcomes, reducing unintended pregnancies, and empowering individuals to make informed choices about their reproductive lives.
Postcoital contraception, also known as emergency contraception, refers to methods used to prevent pregnancy after sexual intercourse has already occurred. These methods are typically used in situations where regular contraception has failed or was not used, such as in cases of condom breakage or forgotten birth control pills.
There are two main types of postcoital contraception:
1. Emergency contraceptive pill (ECP): Also known as the "morning-after pill," this is a hormonal medication that can be taken up to 5 days after unprotected sex, but it is most effective when taken within 72 hours. There are two types of ECPs available: progestin-only and combined estrogen-progestin. The progestin-only pill is preferred because it has fewer side effects and is just as effective as the combined pill.
2. Copper intrauterine device (IUD): This is a small, T-shaped device made of flexible plastic and copper that is inserted into the uterus by a healthcare provider. The IUD can be inserted up to 5 days after unprotected sex to prevent pregnancy. It is the most effective form of emergency contraception available, and it also provides ongoing protection against pregnancy for up to 10 years, depending on the type of IUD.
It's important to note that postcoital contraception should not be used as a regular method of contraception, but rather as a backup in case of emergencies. It is also not effective in preventing sexually transmitted infections (STIs). Regular contraceptive methods, such as condoms and hormonal birth control, are the best ways to prevent unintended pregnancies and STIs.
Foreign-body migration is a medical condition that occurs when a foreign object, such as a surgical implant, tissue graft, or trauma-induced fragment, moves from its original position within the body to a different location. This displacement can cause various complications and symptoms depending on the type of foreign body, the location it migrated to, and the individual's specific physiological response.
Foreign-body migration may result from insufficient fixation or anchoring of the object during implantation, inadequate wound healing, infection, or an inflammatory reaction. Symptoms can include pain, swelling, redness, or infection at the new location, as well as potential damage to surrounding tissues and organs. Diagnosis typically involves imaging techniques like X-rays, CT scans, or MRIs to locate the foreign body, followed by a surgical procedure to remove it and address any resulting complications.
Pyometra is a medical condition that primarily affects female animals, including dogs and cats. It refers to an accumulation of pus in the uterus. This can occur as a result of hormonal changes that lead to the uterine lining becoming thickened and providing a favorable environment for bacterial growth.
The condition is often seen in older, intact (not spayed) females, and it can be caused by a variety of bacteria, with E. coli being one of the most common. If left untreated, pyometra can lead to serious complications, such as sepsis, peritonitis (inflammation of the lining of the abdominal cavity), and even death.
Symptoms of pyometra may include vaginal discharge, lethargy, loss of appetite, vomiting, increased thirst and urination, and abdominal pain or distension. Treatment typically involves surgical removal of the uterus (spaying), as well as supportive care such as fluid therapy and antibiotics to treat any resulting infections.
Unplanned pregnancy is a pregnancy that is not intended or expected by the woman or couple. It is also sometimes referred to as an "unintended" or "unwanted" pregnancy. This can occur when contraceptive methods fail or are not used, or when there is a lack of knowledge about or access to effective family planning resources. Unplanned pregnancies can present various physical, emotional, and social challenges for the individuals involved, and may also have implications for public health and societal well-being. It's important to note that unplanned pregnancies can still result in wanted and loved children, but the circumstances surrounding their conception may bring additional stressors and considerations.
Gynecology is a branch of medicine that deals with the health of the female reproductive system. It includes the diagnosis, treatment, and management of conditions related to the female reproductive organs such as the vagina, cervix, uterus, ovaries, and fallopian tubes.
Gynecologists provide routine care for women, including Pap tests, breast exams, and family planning advice. They also treat a wide range of gynecological issues, from menstrual disorders and sexually transmitted infections to reproductive system cancers and hormonal imbalances. In addition, many gynecologists also provide obstetric care, making them both ob-gyns.
It's important for women to establish a relationship with a trusted gynecologist to ensure they receive regular checkups and are able to address any concerns or issues related to their reproductive health.
Urinary bladder calculi, also known as bladder stones, refer to the formation of solid mineral deposits within the urinary bladder. These calculi develop when urine becomes concentrated, allowing minerals to crystallize and stick together, forming a stone. Bladder stones can vary in size, ranging from tiny sand-like particles to larger ones that can occupy a significant portion of the bladder's volume.
Bladder stones typically form as a result of underlying urinary tract issues, such as bladder infection, enlarged prostate, nerve damage, or urinary retention. Symptoms may include lower abdominal pain, difficulty urinating, frequent urination, blood in the urine, and sudden, strong urges to urinate. If left untreated, bladder stones can lead to complications like urinary tract infections and kidney damage. Treatment usually involves surgical removal of the stones or using other minimally invasive procedures to break them up and remove the fragments.
Uterine hemorrhage, also known as uterine bleeding or gynecological bleeding, is an abnormal loss of blood from the uterus. It can occur in various clinical settings such as menstruation (known as menorrhagia), postpartum period (postpartum hemorrhage), or in non-pregnant women (dysfunctional uterine bleeding). The bleeding may be light to heavy, intermittent or continuous, and can be accompanied by symptoms such as pain, dizziness, or fainting. Uterine hemorrhage is a common gynecological problem that can have various underlying causes, including hormonal imbalances, structural abnormalities, coagulopathies, and malignancies. It is important to seek medical attention if experiencing heavy or prolonged uterine bleeding to determine the cause and receive appropriate treatment.
Contraception behavior refers to the actions and decisions made by individuals or couples to prevent pregnancy. This can include the use of various contraceptive methods, such as hormonal birth control (e.g., pills, patches, rings), barrier methods (e.g., condoms, diaphragms), intrauterine devices (IUDs), and natural family planning techniques (e.g., fertility awareness-based methods).
Contraception behavior can be influenced by various factors, including personal beliefs, cultural norms, relationship dynamics, access to healthcare services, and knowledge about contraceptive options. It is an important aspect of sexual and reproductive health, as it allows individuals and couples to plan their families and make informed choices about whether and when to have children.
It's worth noting that while the term "contraception behavior" typically refers to actions taken specifically to prevent pregnancy, some contraceptive methods may also provide protection against sexually transmitted infections (STIs). For example, condoms are effective at preventing both pregnancy and STIs when used consistently and correctly.
Oral contraceptives, also known as "birth control pills," are medications taken by mouth to prevent pregnancy. They contain synthetic hormones that mimic the effects of natural hormones estrogen and progesterone in a woman's body, thereby preventing ovulation, fertilization, or implantation of a fertilized egg in the uterus.
There are two main types of oral contraceptives: combined pills, which contain both estrogen and progestin, and mini-pills, which contain only progestin. Combined pills work by preventing ovulation, thickening cervical mucus to make it harder for sperm to reach the egg, and thinning the lining of the uterus to make it less likely for a fertilized egg to implant. Mini-pills work mainly by thickening cervical mucus and changing the lining of the uterus.
Oral contraceptives are highly effective when used correctly, but they do not protect against sexually transmitted infections (STIs). It is important to use them consistently and as directed by a healthcare provider. Side effects may include nausea, breast tenderness, headaches, mood changes, and irregular menstrual bleeding. In rare cases, oral contraceptives may increase the risk of serious health problems such as blood clots, stroke, or liver tumors. However, for most women, the benefits of using oral contraceptives outweigh the risks.
Tubal sterilization, also known as female sterilization or tubal ligation, is a permanent form of birth control for women. It involves blocking, sealing, or removing the fallopian tubes, which prevents the sperm from reaching and fertilizing the egg. This procedure can be performed surgically through various methods such as cutting and tying the tubes, using clips or rings to block them, or removing a portion of the tube (known as a partial salpingectomy). Tubal sterilization is considered a highly effective form of contraception with a low failure rate. However, it does not protect against sexually transmitted infections and should be combined with condom use for that purpose. It's important to note that tubal sterilization is a permanent procedure and cannot be easily reversed.
Contraceptive agents are substances or medications that are used to prevent pregnancy by interfering with the normal process of conception and fertilization or the development and implantation of the fertilized egg. They can be divided into two main categories: hormonal and non-hormonal methods.
Hormonal contraceptive agents include combined oral contraceptives (COCs), progestin-only pills, patches, rings, injections, and implants. These methods work by releasing synthetic hormones that mimic the natural hormones estrogen and progesterone in a woman's body. By doing so, they prevent ovulation, thicken cervical mucus to make it harder for sperm to reach the egg, and thin the lining of the uterus to make it less likely for a fertilized egg to implant.
Non-hormonal contraceptive agents include barrier methods such as condoms, diaphragms, cervical caps, and sponges, which prevent sperm from reaching the egg by creating a physical barrier. Other non-hormonal methods include intrauterine devices (IUDs), which are inserted into the uterus to prevent pregnancy, and fertility awareness-based methods, which involve tracking ovulation and avoiding intercourse during fertile periods.
Emergency contraceptive agents, such as Plan B or ella, can also be used to prevent pregnancy after unprotected sex or contraceptive failure. These methods work by preventing or delaying ovulation, preventing fertilization, or preventing implantation of a fertilized egg.
It's important to note that while contraceptive agents are effective at preventing pregnancy, they do not protect against sexually transmitted infections (STIs). Using condoms in addition to other forms of contraception can help reduce the risk of STIs.
Metrorrhagia is defined as uterine bleeding that occurs at irregular intervals, particularly between expected menstrual periods. It can also be described as abnormal vaginal bleeding that is not related to the regular menstrual cycle. The amount of bleeding can vary from light spotting to heavy flow.
Metrorrhagia is different from menorrhagia, which refers to excessive or prolonged menstrual bleeding during the menstrual period. Metrorrhagia can be caused by various factors, including hormonal imbalances, uterine fibroids, polyps, endometrial hyperplasia, infection, pregnancy complications, and certain medications or medical conditions.
It is essential to consult a healthcare provider if you experience any abnormal vaginal bleeding to determine the underlying cause and receive appropriate treatment.
Ectopic pregnancy is a type of abnormal pregnancy that occurs outside the uterine cavity. The most common site for an ectopic pregnancy is the fallopian tube, accounting for about 95% of cases. This condition is also known as tubal pregnancy. Other less common sites include the ovary, cervix, and abdominal cavity.
In a normal pregnancy, the fertilized egg travels down the fallopian tube and implants itself in the lining of the uterus. However, in an ectopic pregnancy, the fertilized egg implants and starts to develop somewhere other than the uterus. The growing embryo cannot survive outside the uterus, and if left untreated, an ectopic pregnancy can cause life-threatening bleeding due to the rupture of the fallopian tube or other organs.
Symptoms of ectopic pregnancy may include abdominal pain, vaginal bleeding, shoulder pain, lightheadedness, fainting, and in severe cases, shock. Diagnosis is usually made through a combination of medical history, physical examination, ultrasound, and blood tests to measure the levels of human chorionic gonadotropin (hCG), a hormone produced during pregnancy.
Treatment for ectopic pregnancy depends on several factors, including the location, size, and growth rate of the ectopic mass, as well as the patient's overall health and desire for future pregnancies. Treatment options may include medication to stop the growth of the embryo or surgery to remove the ectopic tissue. In some cases, both methods may be used together. Early diagnosis and treatment can help prevent serious complications and improve the chances of preserving fertility in future pregnancies.
Hysteroscopy is a diagnostic procedure that allows healthcare professionals to examine the interior of the uterus (hyster(o)- and -scopy from Greek "womb" + "examination"). It is performed using a hysteroscope, which is a thin, lighted tube with a camera attached to its end. The hysteroscope is inserted through the vagina and cervix into the uterus, enabling the visualization of the uterine cavity and the detection of any abnormalities, such as polyps, fibroids, or structural issues like a septum.
Hysteroscopy can be performed in a doctor's office or an outpatient surgical center under local, regional, or general anesthesia depending on the situation and patient comfort. The procedure may also be used for minor surgical interventions, such as removing polyps or fibroids, or to assist with other procedures like laparoscopy.
In summary, hysteroscopy is a medical examination of the uterine cavity using a thin, lighted tube called a hysteroscope, which can aid in diagnosing and treating various conditions affecting the uterus.
Oral hormonal contraceptives, also known as "birth control pills," are a type of medication that contains synthetic hormones (estrogen and/or progestin) that are taken by mouth to prevent pregnancy. They work by preventing ovulation (the release of an egg from the ovaries), thickening cervical mucus to make it harder for sperm to reach the egg, and thinning the lining of the uterus to make it less likely for a fertilized egg to implant.
There are several different types of oral hormonal contraceptives, including combined pills that contain both estrogen and progestin, and mini-pills that only contain progestin. These medications are usually taken daily for 21 days, followed by a seven-day break during which menstruation occurs. Some newer formulations may be taken continuously with no break.
It's important to note that while oral hormonal contraceptives are highly effective at preventing pregnancy when used correctly, they do not protect against sexually transmitted infections (STIs). Therefore, it is still important to use barrier methods of protection, such as condoms, during sexual activity to reduce the risk of STIs.
As with any medication, oral hormonal contraceptives can have side effects and may not be suitable for everyone. It's important to discuss any medical conditions, allergies, or medications you are taking with your healthcare provider before starting to take oral hormonal contraceptives.
Pregnancy is a physiological state or condition where a fertilized egg (zygote) successfully implants and grows in the uterus of a woman, leading to the development of an embryo and finally a fetus. This process typically spans approximately 40 weeks, divided into three trimesters, and culminates in childbirth. Throughout this period, numerous hormonal and physical changes occur to support the growing offspring, including uterine enlargement, breast development, and various maternal adaptations to ensure the fetus's optimal growth and well-being.
Reproductive sterilization is a surgical procedure that aims to prevent reproduction by making an individual unable to produce viable reproductive cells or preventing the union of sperm and egg. In males, this is often achieved through a vasectomy, which involves cutting and sealing the vas deferens, the tubes that carry sperm from the testicles to the urethra. In females, sterilization is typically performed via a procedure called tubal ligation, where the fallopian tubes are cut, tied, or sealed, preventing the egg from traveling from the ovaries to the uterus and blocking sperm from reaching the egg. These methods are considered permanent forms of contraception; however, in rare cases, reversals may be attempted with varying degrees of success.
A hysteroscope is a thin, lighted tube with a camera that is used to examine the inside of the uterus. It is inserted through the vagina and cervix, allowing the healthcare provider to view the lining of the uterus and the openings of the fallopian tubes on a video screen. Hysteroscopy can be used to diagnose and treat various conditions affecting the uterus, such as abnormal bleeding, fibroids, polyps, and adhesions (scar tissue). It is typically performed as an outpatient procedure in a doctor's office or clinic.
Desogestrel is a synthetic form of progestin, which is a female sex hormone. It is used in various forms of hormonal contraception such as birth control pills, patches, and vaginal rings to prevent pregnancy. Desogestrel works by preventing ovulation (the release of an egg from the ovaries), thickening cervical mucus to make it harder for sperm to reach the egg, and thinning the lining of the uterus to make it less likely for a fertilized egg to implant.
Desogestrel is also used in some hormone replacement therapies (HRT) to treat symptoms of menopause such as hot flashes and vaginal dryness. It may be prescribed alone or in combination with estrogen.
Like all hormonal contraceptives, desogestrel has potential side effects, including irregular menstrual bleeding, headaches, mood changes, breast tenderness, and nausea. In rare cases, it may also increase the risk of blood clots, stroke, or heart attack. It is important to discuss the risks and benefits of desogestrel with a healthcare provider before using it.
Menstruation is the regular, cyclical shedding of the uterine lining (endometrium) in women and female individuals of reproductive age, accompanied by the discharge of blood and other materials from the vagina. It typically occurs every 21 to 35 days and lasts for approximately 2-7 days. This process is a part of the menstrual cycle, which is under the control of hormonal fluctuations involving follicle-stimulating hormone (FSH), luteinizing hormone (LH), estrogen, and progesterone.
The menstrual cycle can be divided into three main phases:
1. Menstruation phase: The beginning of the cycle is marked by the start of menstrual bleeding, which signals the breakdown and shedding of the endometrium due to the absence of pregnancy and low levels of estrogen and progesterone. This phase typically lasts for 2-7 days.
2. Proliferative phase: After menstruation, under the influence of rising estrogen levels, the endometrium starts to thicken and regenerate. The uterine lining becomes rich in blood vessels and glands, preparing for a potential pregnancy. This phase lasts from day 5 until around day 14 of an average 28-day cycle.
3. Secretory phase: Following ovulation (release of an egg from the ovaries), which usually occurs around day 14, increased levels of progesterone cause further thickening and maturation of the endometrium. The glands in the lining produce nutrients to support a fertilized egg. If pregnancy does not occur, both estrogen and progesterone levels will drop, leading to menstruation and the start of a new cycle.
Understanding menstruation is essential for monitoring reproductive health, identifying potential issues such as irregular periods or menstrual disorders, and planning family planning strategies.
The cervix is the lower, narrow part of the uterus that opens into the vagina. Cervical mucus is a clear or cloudy secretion produced by glands in the cervix. The amount and consistency of cervical mucus changes throughout a woman's menstrual cycle, influenced by hormonal fluctuations.
During the fertile window (approximately mid-cycle), estrogen levels rise, causing the cervical mucus to become more abundant, clear, and stretchy (often described as resembling raw egg whites). This "fertile" mucus facilitates the movement of sperm through the cervix and into the uterus, increasing the chances of fertilization.
As the menstrual cycle progresses and progesterone levels rise after ovulation, cervical mucus becomes thicker, cloudier, and less abundant, making it more difficult for sperm to penetrate. This change in cervical mucus helps prevent additional sperm from entering and fertilizing an already-fertilized egg.
Changes in cervical mucus can be used as a method of natural family planning or fertility awareness, with women checking their cervical mucus daily to identify their most fertile days. However, this method should be combined with other tracking methods for increased accuracy and reliability.
Unwanted pregnancy is a situation where a person becomes pregnant despite not planning or desiring to conceive at that time. This can occur due to various reasons such as lack of access to effective contraception, failure of contraceptive methods, sexual assault, or a change in circumstances that makes the pregnancy untimely or inconvenient. Unwanted pregnancies can have significant physical, emotional, and socioeconomic impacts on individuals and families. It is important to address unwanted pregnancies through comprehensive sexuality education, access to affordable and effective contraception, and supportive services for those who experience unintended pregnancies.
The postpartum period refers to the time frame immediately following childbirth, typically defined as the first 6-12 weeks. During this time, significant physical and emotional changes occur as the body recovers from pregnancy and delivery. Hormone levels fluctuate dramatically, leading to various symptoms such as mood swings, fatigue, and breast engorgement. The reproductive system also undergoes significant changes, with the uterus returning to its pre-pregnancy size and shape, and the cervix closing.
It is essential to monitor physical and emotional health during this period, as complications such as postpartum depression, infection, or difficulty breastfeeding may arise. Regular check-ups with healthcare providers are recommended to ensure a healthy recovery and address any concerns. Additionally, proper rest, nutrition, and support from family and friends can help facilitate a smooth transition into this new phase of life.
Induced abortion is a medical procedure that intentionally terminates a pregnancy before the fetus can survive outside the womb. It can be performed either surgically or medically through the use of medications. The timing of an induced abortion is typically based on the gestational age of the pregnancy, with different methods used at different stages.
The most common surgical procedure for induced abortion is vacuum aspiration, which is usually performed during the first trimester (up to 12-13 weeks of gestation). This procedure involves dilating the cervix and using a vacuum device to remove the pregnancy tissue from the uterus. Other surgical procedures, such as dilation and evacuation (D&E), may be used in later stages of pregnancy.
Medical abortion involves the use of medications to induce the termination of a pregnancy. The most common regimen involves the use of two drugs: mifepristone and misoprostol. Mifepristone works by blocking the action of progesterone, a hormone necessary for maintaining pregnancy. Misoprostol causes the uterus to contract and expel the pregnancy tissue. This method is typically used during the first 10 weeks of gestation.
Induced abortion is a safe and common medical procedure, with low rates of complications when performed by trained healthcare providers in appropriate settings. Access to induced abortion varies widely around the world, with some countries restricting or prohibiting the practice entirely.
Menorrhagia is a medical term used to describe abnormally heavy or prolonged menstrual periods. It's often characterized by the loss of an excessive amount of menstrual blood (usually more than 80 ml) and can last longer than normal, typically over seven days. This condition can have significant impacts on a woman's quality of life, causing fatigue, distress, and restrictions in daily activities due to the need for frequent pad or tampon changes.
The causes of menorrhagia are varied and can include hormonal imbalances, uterine fibroids or polyps, endometrial hyperplasia, pelvic inflammatory disease, pregnancy complications, certain medications, and underlying medical conditions such as coagulopathies or thyroid disorders. In some cases, the cause may remain undetermined even after a thorough evaluation.
Treatment options for menorrhagia depend on the underlying cause and range from medication management with hormonal therapies, nonsteroidal anti-inflammatory drugs (NSAIDs), or tranexamic acid to procedural interventions like endometrial ablation, hysteroscopic resection of polyps or fibroids, or ultimately hysterectomy in severe cases. It is essential for individuals experiencing menorrhagia to consult with their healthcare provider to determine the best course of action based on their specific situation and medical history.
Progestins are a class of steroid hormones that are similar to progesterone, a natural hormone produced by the ovaries during the menstrual cycle and pregnancy. They are often used in hormonal contraceptives, such as birth control pills, shots, and implants, to prevent ovulation and thicken the cervical mucus, making it more difficult for sperm to reach the egg. Progestins are also used in menopausal hormone therapy to alleviate symptoms of menopause, such as hot flashes and vaginal dryness. Additionally, progestins may be used to treat endometriosis, uterine fibroids, and breast cancer. Different types of progestins have varying properties and may be more suitable for certain indications or have different side effect profiles.
Medroxyprogesterone is a synthetic form of the natural hormone progesterone, which is a female sex hormone produced by the corpus luteum during the menstrual cycle and by the placenta during pregnancy. As a medication, medroxyprogesterone is used to treat a variety of conditions, including:
* Abnormal menstrual bleeding
* Endometrial hyperplasia (overgrowth of the lining of the uterus)
* Contraception (birth control)
* Hormone replacement therapy in postmenopausal women
* Prevention of breast cancer in high-risk women
* Treatment of certain types of cancer, such as endometrial and renal cancers
Medroxyprogesterone works by binding to progesterone receptors in the body, which helps to regulate the menstrual cycle, maintain pregnancy, and prevent the growth of some types of cancer. It is available in various forms, including tablets, injectable solutions, and depot suspensions for intramuscular injection.
It's important to note that medroxyprogesterone can have significant side effects, and its use should be monitored by a healthcare provider. Women who are pregnant or breastfeeding should not take medroxyprogesterone, and it may interact with other medications, so it is important to inform your doctor of all medications you are taking before starting medroxyprogesterone.
"Device approval" is a term used to describe the process by which a medical device is determined to be safe and effective for use in patients by regulatory authorities, such as the U.S. Food and Drug Administration (FDA). The approval process typically involves a rigorous evaluation of the device's design, performance, and safety data, as well as a review of the manufacturer's quality systems and labeling.
The FDA's Center for Devices and Radiological Health (CDRH) is responsible for regulating medical devices in the United States. The CDRH uses a risk-based classification system to determine the level of regulatory control needed for each device. Class I devices are considered low risk, Class II devices are moderate risk, and Class III devices are high risk.
For Class III devices, which include life-sustaining or life-supporting devices, as well as those that present a potential unreasonable risk of illness or injury, the approval process typically involves a premarket approval (PMA) application. This requires the submission of comprehensive scientific evidence to demonstrate the safety and effectiveness of the device.
For Class II devices, which include moderate-risk devices such as infusion pumps and powered wheelchairs, the approval process may involve a premarket notification (510(k)) submission. This requires the manufacturer to demonstrate that their device is substantially equivalent to a predicate device that is already legally marketed in the United States.
Once a medical device has been approved for marketing, the FDA continues to monitor its safety and effectiveness through post-market surveillance programs. Manufacturers are required to report any adverse events or product problems to the FDA, and the agency may take regulatory action if necessary to protect public health.
Medroxyprogesterone Acetate (MPA) is a synthetic form of the natural hormone progesterone, which is often used in various medical applications. It is a white to off-white crystalline powder, slightly soluble in water, and freely soluble in alcohol, chloroform, and methanol.
Medically, MPA is used as a prescription medication for several indications, including:
1. Contraception: As an oral contraceptive or injectable solution, it can prevent ovulation, thicken cervical mucus to make it harder for sperm to reach the egg, and alter the lining of the uterus to make it less likely for a fertilized egg to implant.
2. Hormone replacement therapy (HRT): In postmenopausal women, MPA can help manage symptoms associated with decreased estrogen levels, such as hot flashes and vaginal dryness. It may also help prevent bone loss (osteoporosis).
3. Endometrial hyperplasia: MPA can be used to treat endometrial hyperplasia, a condition where the lining of the uterus becomes too thick, which could potentially lead to cancer if left untreated. By opposing the effects of estrogen, MPA helps regulate the growth of the endometrium.
4. Gynecological disorders: MPA can be used to treat various gynecological disorders, such as irregular menstrual cycles, amenorrhea (absence of menstruation), and dysfunctional uterine bleeding.
5. Cancer treatment: In some cases, MPA may be used in conjunction with other medications to treat certain types of breast or endometrial cancer.
As with any medication, Medroxyprogesterone Acetate can have side effects and potential risks. It is essential to consult a healthcare professional for proper evaluation, dosage, and monitoring when considering this medication.
A drug implant is a medical device that is specially designed to provide controlled release of a medication into the body over an extended period of time. Drug implants can be placed under the skin or in various body cavities, depending on the specific medical condition being treated. They are often used when other methods of administering medication, such as oral pills or injections, are not effective or practical.
Drug implants come in various forms, including rods, pellets, and small capsules. The medication is contained within the device and is released slowly over time, either through diffusion or erosion of the implant material. This allows for a steady concentration of the drug to be maintained in the body, which can help to improve treatment outcomes and reduce side effects.
Some common examples of drug implants include:
1. Hormonal implants: These are small rods that are inserted under the skin of the upper arm and release hormones such as progestin or estrogen over a period of several years. They are often used for birth control or to treat conditions such as endometriosis or uterine fibroids.
2. Intraocular implants: These are small devices that are placed in the eye during surgery to release medication directly into the eye. They are often used to treat conditions such as age-related macular degeneration or diabetic retinopathy.
3. Bone cement implants: These are specially formulated cements that contain antibiotics and are used to fill bone defects or joint spaces during surgery. The antibiotics are released slowly over time, helping to prevent infection.
4. Implantable pumps: These are small devices that are placed under the skin and deliver medication directly into a specific body cavity, such as the spinal cord or the peritoneal cavity. They are often used to treat chronic pain or cancer.
Overall, drug implants offer several advantages over other methods of administering medication, including improved compliance, reduced side effects, and more consistent drug levels in the body. However, they may also have some disadvantages, such as the need for surgical placement and the potential for infection or other complications. As with any medical treatment, it is important to discuss the risks and benefits of drug implants with a healthcare provider.
The pelvis is the lower part of the trunk, located between the abdomen and the lower limbs. It is formed by the fusion of several bones: the ilium, ischium, and pubis (which together form the hip bone on each side), and the sacrum and coccyx in the back. The pelvis has several functions including supporting the weight of the upper body when sitting, protecting the lower abdominal organs, and providing attachment for muscles that enable movement of the lower limbs. In addition, it serves as a bony canal through which the reproductive and digestive tracts pass. The pelvic cavity contains several vital organs such as the bladder, parts of the large intestine, and in females, the uterus, ovaries, and fallopian tubes.
Intestinal perforation is a medical condition that refers to a hole or tear in the lining of the intestine. This can occur anywhere along the gastrointestinal tract, including the small intestine, large intestine (colon), or stomach. Intestinal perforation allows the contents of the intestines, such as digestive enzymes and bacteria, to leak into the abdominal cavity, which can lead to a serious inflammatory response known as peritonitis.
Intestinal perforation can be caused by various factors, including:
* Mechanical trauma (e.g., gunshot wounds, stab wounds)
* Inflammatory bowel disease (e.g., Crohn's disease, ulcerative colitis)
* Diverticulitis
* Appendicitis
* Intestinal obstruction
* Infections (e.g., typhoid fever, tuberculosis)
* Certain medications (e.g., nonsteroidal anti-inflammatory drugs, corticosteroids)
* Radiation therapy
* Ischemic bowel disease (lack of blood flow to the intestines)
Symptoms of intestinal perforation may include sudden abdominal pain, nausea, vomiting, fever, and decreased bowel movements. Treatment typically involves surgery to repair the perforation and remove any damaged tissue. Antibiotics are also administered to prevent infection. In severe cases, a temporary or permanent colostomy or ileostomy may be necessary.
The uterus, also known as the womb, is a hollow, muscular organ located in the female pelvic cavity, between the bladder and the rectum. It has a thick, middle layer called the myometrium, which is composed of smooth muscle tissue, and an inner lining called the endometrium, which provides a nurturing environment for the fertilized egg to develop into a fetus during pregnancy.
The uterus is where the baby grows and develops until it is ready for birth through the cervix, which is the lower, narrow part of the uterus that opens into the vagina. The uterus plays a critical role in the menstrual cycle as well, by shedding its lining each month if pregnancy does not occur.
In medical terms, parity refers to the number of times a woman has given birth to a viable fetus, usually defined as a pregnancy that reaches at least 20 weeks' gestation. It is often used in obstetrics and gynecology to describe a woman's childbearing history and to assess potential risks associated with childbirth.
Parity is typically categorized as follows:
* Nulliparous: A woman who has never given birth to a viable fetus.
* Primiparous: A woman who has given birth to one viable fetus.
* Multiparous: A woman who has given birth to more than one viable fetus.
In some cases, parity may also consider the number of pregnancies that resulted in stillbirths or miscarriages, although this is not always the case. It's important to note that parity does not necessarily reflect the total number of pregnancies a woman has had, only those that resulted in viable births.
The endometrium is the innermost layer of the uterus, which lines the uterine cavity and has a critical role in the menstrual cycle and pregnancy. It is composed of glands and blood vessels that undergo cyclic changes under the influence of hormones, primarily estrogen and progesterone. During the menstrual cycle, the endometrium thickens in preparation for a potential pregnancy. If fertilization does not occur, it will break down and be shed, resulting in menstruation. In contrast, if implantation takes place, the endometrium provides essential nutrients to support the developing embryo and placenta throughout pregnancy.